Are Immune Checkpoint Inhibitors Effective Against Uncommon Oncogene-Driven NSCLC Subtypes?

  1. Eguren-Santamaria, I.
  2. Sanmamed, M.F.
  3. Gil-Bazo, I.
Revue:
Journal of Thoracic Oncology

ISSN: 1556-1380,  1556-0864

Année de publication: 2020

Volumen: 15

Número: 4

Pages: 489-492

Type: Éditorial

DOI: 10.1016/J.JTHO.2020.02.003 GOOGLE SCHOLAR lock_openAccès ouvert editor
La source de données: Scopus